The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Please check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.
Notice of Funding Opportunities
| Title Sort ascending | Announcement Number | Activity Code | Clinical Trials Status | Expiration Date | Program Official |
|---|---|---|---|---|---|
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-25-074 (UH2/UH3 Clinical Trial Not Allowed) | UH2, UH3 | Clinical Trial Not Allowed | 10/14/2026 | Sudhir Srivastava, Ph.D., M.P.H. |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-25-075 (UH3 Clinical Trials Not Allowed) | UH3 | 10/14/2026 | Sudhir Srivastava, Ph.D., M.P.H. |